Prestige Consumer Healthcare Inc.
PBH· NYSE
PBHPrestige Consumer Healthcare Inc.
Filed May 5, 2023 · 10-K · 35 days after period end · 0001295947-23-000017
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | $285.87M | $266.94M | $237.76M | $251.24M |
| Net Income | -$240.55M | $52.09M | $35.51M | $37.05M |
| EPS Diluted | — | — |
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
| — |
| $0.73 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Mar 31, 2023 · filed May 5, 2023 · 35 d after period end
